Roche Holding AG (OTCQX International Premier:RHHVF)

316.00
Delayed Data
As of Sep 30
 -19.00 / -5.67%
Today’s Change
299.01
Today|||52-Week Range
430.00
-22.20%
Year-to-Date
Can Biogen (BIIB) Navigate Multiple Challenges & Grow Again?
9:15am / Zacks.com - Paid Partner Content
Biogen's (BIIB) Lecanemab Meets Goal in Alzheimer's Study
Sep 28 / Zacks.com - Paid Partner Content
What This News Means for Merck
Oct 01 / MotleyFool.com - Paid Partner Content
Seagen (SGEN) Inks Deal With LAVA Therapeutics for LAVA-1223
Sep 27 / Zacks.com - Paid Partner Content
Sarepta (SRPT) Seeks FDA Nod for DMD Gene Therapy Candidate
Sep 30 / Zacks.com - Paid Partner Content
Novartis (NVS) to Focus on US Markets Backed by 8 Key Drugs
Sep 23 / Zacks.com - Paid Partner Content
NVS vs. RHHBY: Which Stock Should Value Investors Buy Now?
Sep 29 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: EU Nod to AZN & RHHBY Drugs, FDA Updates for LLY & MRK
Sep 23 / Zacks.com - Paid Partner Content
LLY & PRTA in Spotlight on BIIB-Eisai's AD Drug Data
Sep 29 / Zacks.com - Paid Partner Content
Novartis (NVS) to Appeal to Supreme Court for Gilenya Patent
Sep 22 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close335.00
Today’s open333.89
Day’s range313.00 - 333.89
Volume80,408
Average volume (3 months)7,096
Market cap$219.3B
Data as of 09/30/2022

Growth & Valuation

Earnings growth (last year)+0.63%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+10.55%
P/E ratio--
Price/Sales5.21
Price/Book9.41

Competitors

No competitors data available.

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$68.7B
Annual profit (last year)$15.2B
Net profit margin22.18%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Basel, Basel-stadt (basle Town)

Forecasts

Chart unavailable